A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response. [electronic resource]
- Vaccine Aug 2011
- 6292-300 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural